By Maya Rajamani ( November 2, 2015, 5:46 PM EST) -- Four life science companies set terms for initial public offerings totaling about $276 million at their midpoint prices on Monday, joining the recent spate of biotech and health care-related offerings that one expert said could "create a return in the demand for life science IPOs."...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.